Page 1 of 4.
Curetis Provides Update on Unyvero LRT FDA 510(k) Submission
Curetis Provides Business and Financial Update for the First Quarter 2017
Curetis to Hold Annual General Shareholders’ Meeting on June 23, 2017
Recent Data on Curetis’ Unyvero ITI Application Demonstrate its Clinical and Health Economic Benefits
Curetis’ Unyvero Intra-Abdominal Infection (IAI) Cartridge Receives CE Marking
ATS - American Thoracic Society, Washington D.C., USA - May 19 to 24, 2017
SHEA - The Society for Healthcare Epidemiology of America, St. Louis, MO, USA - May 29 to 30, 2017